Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

2.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

787
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
787
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

13.6K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors.

Journal of diabetes science and technology·2024
Same author

Correction: Diabetes technology in people with diabetes and advanced chronic kidney disease.

Diabetologia·2024
Same author

Diabetes technology in people with diabetes and advanced chronic kidney disease.

Diabetologia·2024
Same author

Identifying the deficiencies of currently available CGM to improve uptake and benefit.

Diabetic medicine : a journal of the British Diabetic Association·2024
Same author

Macroergonomic components of the patient work system shaping dyadic care management during adolescence: a case study of type 1 diabetes.

Ergonomics·2024
Same author

Injection Technique: Development of a Novel Questionnaire and User Guide.

Diabetes spectrum : a publication of the American Diabetes Association·2021

Related Experiment Video

Updated: Dec 27, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

633

Social Inequality and Diabetes: A Commentary.

Katharine D Barnard-Kelly1, Daniel Cherñavvsky2,3

  • 1Faculty of Health and Social Science, Bournemouth University, Bournemouth, UK. katharinebarnard@bhrltd.com.

Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|March 4, 2020
PubMed
Summary

Healthcare access disparities, particularly for diabetes management technologies, create unfair health outcomes. Investigating these inequalities is crucial for equitable patient care and improved diabetes outcomes.

Keywords:
DiabetesDiabetes technologiesGlycaemic controlSocial deprivationSocial inequality

More Related Videos

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

71.1K
Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
05:54

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature

Published on: January 24, 2025

592

Related Experiment Videos

Last Updated: Dec 27, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

633
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

71.1K
Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
05:54

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature

Published on: January 24, 2025

592

Area of Science:

  • Public Health
  • Health Services Research
  • Health Economics

Background:

  • Socioeconomic factors significantly impact healthcare access and outcomes across various medical fields.
  • Health inequalities are defined as unfair and preventable differences in health status arising from unequal social, environmental, and economic conditions.
  • Access to advanced diabetes technologies has shown potential to improve glycaemic control and quality of life.

Purpose of the Study:

  • To highlight key issues surrounding healthcare inequalities in diabetes management.
  • To investigate the causes of disparities in access to diabetes care and technologies.
  • To underscore the need for equitable distribution of healthcare resources.

Main Methods:

  • Analysis of National Diabetes Audit data to identify variations in technology use.
  • Review of existing literature on socioeconomic determinants of health.
  • Discussion of policy implications for equitable healthcare access.

Main Results:

  • Significant tenfold variation in insulin pump usage among people with type 1 diabetes across specialist centers.
  • Evidence suggests systemic issues within healthcare systems contribute to unequal access.
  • Disparities in access to diabetes management technologies are linked to socioeconomic factors.

Conclusions:

  • Healthcare inequalities in diabetes management are a significant concern requiring urgent attention.
  • Variations in technology access indicate a need for systemic investigation and intervention.
  • Addressing socioeconomic disparities is essential for achieving equitable diabetes care and outcomes.